Effect of trilaciclib, a CDK 4/6 inhibitor, on myelosuppression in patients with previously treated extensive-stage small cell lung cancer receiving topotecan.

Hart, Lowell L; Andric, Zoran G; ...; Radosavljevic, Davorin Z; Jovanovic, Dragana; ...; Samarzija, Miroslav; Zaric, Bojan; ...; (broj, koautora 20)

Results

eNauka > Results > Effect of trilaciclib, a CDK 4/6 inhibitor, on myelosuppression in patients with previously treated extensive-stage small cell lung cancer receiving topotecan.

Title:	Effect of trilaciclib, a CDK 4/6 inhibitor, on myelosuppression in patients with previously treated extensive-stage small cell lung cancer receiving topotecan.
Authors:	Hart, Lowell L; Andric, Zoran G ; ...; Radosavljevic, Davorin Z; Jovanovic, Dragana; ...; Samarzija, Miroslav; Zaric, Bojan ; ...; (broj, koautora 20)
Issue Date:	2019
Publication:	JOURNAL OF CLINICAL ONCOLOGY
ISSN:	0732-183X Journal of Clinical Oncology Search Idenfier
Type:	Conference Paper
Collation:	vol. 37 br. 15
WoS-ID:	000487345806383
URI:	https://enauka.gov.rs/handle/123456789/821435
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

8
WEB OF SCIENCE^TM

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM